Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.

Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA.

Malar J. 2016 May 21;15(1):285. doi: 10.1186/s12936-016-1339-x.

2.

Design of a study to determine the impact of insecticide resistance on malaria vector control: a multi-country investigation.

Kleinschmidt I, Mnzava AP, Kafy HT, Mbogo C, Bashir AI, Bigoga J, Adechoubou A, Raghavendra K, Knox TB, Malik EM, Nkuni ZJ, Bayoh N, Ochomo E, Fondjo E, Kouambeng C, Awono-Ambene HP, Etang J, Akogbeto M, Bhatt R, Swain DK, Kinyari T, Njagi K, Muthami L, Subramaniam K, Bradley J, West P, Massougbodji A, Okê-Sopoh M, Hounto A, Elmardi K, Valecha N, Kamau L, Mathenge E, Donnelly MJ.

Malar J. 2015 Jul 22;14:282. doi: 10.1186/s12936-015-0782-4.

3.

Do frontline health care providers know enough about artemisinin-based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan.

Mannan AA, Elmardi KA, Idris YA, Spector JM, Ali NA, Malik EM.

Malar J. 2015 Mar 26;14:131. doi: 10.1186/s12936-015-0652-0.

4.

Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance.

Elmannan AA, Elmardi KA, Idris YA, Spector JM, Ali NA, Malik EM.

BMC Pharmacol Toxicol. 2015 Mar 26;16:3. doi: 10.1186/s40360-015-0002-4.

5.

Poor adherence to the malaria management protocol among health workers attending under-five year old febrile children at Omdurman Hospital, Sudan.

Bilal JA, Gasim GI, Abdien MT, Elmardi KA, Malik EM, Adam I.

Malar J. 2015 Jan 28;14:34. doi: 10.1186/s12936-015-0575-9.

6.

Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.

Abdallah TM, Elmardi KA, Elhassan AH, Omer MB, Elhag MS, Desogi MA, Siddig MF, Adam I.

J Infect Dev Ctries. 2014 May 14;8(5):611-5. doi: 10.3855/jidc.3813.

7.

Malaria risk mapping for control in the republic of Sudan.

Noor AM, ElMardi KA, Abdelgader TM, Patil AP, Amine AA, Bakhiet S, Mukhtar MM, Snow RW.

Am J Trop Med Hyg. 2012 Dec;87(6):1012-21. doi: 10.4269/ajtmh.2012.12-0390. Epub 2012 Oct 1.

8.

Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey.

Abdelgader TM, Ibrahim AM, Elmardi KA, Githinji S, Zurovac D, Snow RW, Noor AM.

BMC Public Health. 2012 Jan 6;12:11. doi: 10.1186/1471-2458-12-11.

9.

Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan.

Elmardi KA, Noor AM, Githinji S, Abdelgadir TM, Malik EM, Snow RW.

Malar J. 2011 May 15;10:128. doi: 10.1186/1475-2875-10-128.

10.

Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.

Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J; Leishmaniasis East Africa Platform (LEAP) group..

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e709. doi: 10.1371/journal.pntd.0000709.

11.

Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan.

Adam I, Salah MT, Eltahir HG, Elhassan AH, Elmardi KA, Malik EM.

Ann Trop Med Parasitol. 2010 Jun;104(4):319-26. doi: 10.1179/136485910X12743554760144.

PMID:
20659392
12.

Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.

Elamin SB, Awad AI, Eltayeb IB, Elmardi KA, Hassan AH, Mohamed AO, Malik EM, Mohamad TA.

Eur J Clin Pharmacol. 2010 Mar;66(3):231-7.

PMID:
20187287
13.

Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.

Elmardi KA, Malik EM, Abdelgadir T, Ali SH, Elsyed AH, Mudather MA, Elhassan AH, Adam I.

Malar J. 2009 Mar 9;8:39. doi: 10.1186/1475-2875-8-39.

14.

Predictors of antimalarial treatment failure in an area of unstable malaria transmission in eastern Sudan.

Adam I, Elmardi KA, Malik EM.

Trans R Soc Trop Med Hyg. 2009 Jan;103(1):21-4. doi: 10.1016/j.trstmh.2008.07.005. Epub 2008 Aug 20.

PMID:
18718621
15.

The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria.

Adam I, Elhardello OA, Elhadi MO, Abdalla E, Elmardi KA, Jansen FH.

Ann Trop Med Parasitol. 2008 Jan;102(1):39-44. doi: 10.1179/136485908X252214.

PMID:
18186976
16.

Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.

Ibrahium AM, Kheir MM, Osman ME, Khalil IF, Alifrangis M, Elmardi KA, Malik EM, Adam I.

Ann Trop Med Parasitol. 2007 Jan;101(1):15-21.

PMID:
17244406
17.
18.

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB, Mannan AA, Ahmed ES.

Malar J. 2006 Jul 31;5:65.

19.

From home to hospital: beliefs and practices related to severe malaria in Sudan.

Malik EM, Nour SM, Hamid IK, Elmardi KA, Mohamed TA, Ahmed ES.

J Family Community Med. 2005 May;12(2):85-90.

Supplemental Content

Loading ...
Support Center